Literature DB >> 23827948

The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.

Wenzhang Wang1, Li Li, Wen-Lang Lin, Dennis W Dickson, Leonard Petrucelli, Teng Zhang, Xinglong Wang.   

Abstract

Mutations in TDP-43 lead to familial ALS. Expanding evidence suggests that impaired mitochondrial dynamics likely contribute to the selective degeneration of motor neurons in SOD1-associated ALS. In this study, we investigated whether and how TDP-43 mutations might impact mitochondrial dynamics and function. We demonstrated that overexpression of wild-type TDP-43 resulted in reduced mitochondrial length and density in neurites of primary motor neurons, features further exacerbated by ALS-associated TDP-43 mutants Q331K and M337V. In contrast, suppression of TDP-43 resulted in significantly increased mitochondrial length and density in neurites, suggesting a specific role of TDP-43 in regulating mitochondrial dynamics. Surprisingly, both TDP-43 overexpression and suppression impaired mitochondrial movement. We further showed that abnormal localization of TDP-43 in cytoplasm induced substantial and widespread abnormal mitochondrial dynamics. TDP-43 co-localized with mitochondria in motor neurons and their colocalization was enhanced by ALS associated mutant. Importantly, co-expression of mitochondrial fusion protein mitofusin 2 (Mfn2) could abolish TDP-43 induced mitochondrial dynamics abnormalities and mitochondrial dysfunction. Taken together, these data suggest that mutant TDP-43 impairs mitochondrial dynamics through enhanced localization on mitochondria, which causes mitochondrial dysfunction. Therefore, abnormal mitochondrial dynamics is likely a common feature of ALS which could be potential new therapeutic targets to treat ALS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23827948      PMCID: PMC3820133          DOI: 10.1093/hmg/ddt319

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  TDP43-positive intraneuronal inclusions in a patient with motor neuron disease and Parkinson's disease.

Authors:  Jean-Baptiste Chanson; Andoni Echaniz-Laguna; Thomas Vogel; Michel Mohr; Aurélien Benoilid; Georges Kaltenbach; Michèle Kiesmann
Journal:  Neurodegener Dis       Date:  2010-02-27       Impact factor: 2.977

Review 2.  TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies.

Authors:  Todd J Cohen; Virginia M Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2011-07-23       Impact factor: 11.951

3.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

4.  Computer-assisted live cell analysis of mitochondrial membrane potential, morphology and calcium handling.

Authors:  Werner J H Koopman; Felix Distelmaier; John J Esseling; Jan A M Smeitink; Peter H G M Willems
Journal:  Methods       Date:  2008-10-16       Impact factor: 3.608

5.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

6.  TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis.

Authors:  Maria Teresa Giordana; Marco Piccinini; Silvia Grifoni; Giovanni De Marco; Marco Vercellino; Michela Magistrello; Alessia Pellerino; Barbara Buccinnà; Elisa Lupino; Maria Teresa Rinaudo
Journal:  Brain Pathol       Date:  2009-03-17       Impact factor: 6.508

7.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

8.  Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.

Authors:  Ya-Fei Xu; Yong-Jie Zhang; Wen-Lang Lin; Xiangkun Cao; Caroline Stetler; Dennis W Dickson; Jada Lewis; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2011-10-26       Impact factor: 14.195

9.  Local translation of extranuclear lamin B promotes axon maintenance.

Authors:  Byung C Yoon; Hosung Jung; Asha Dwivedy; Catherine M O'Hare; Krishna H Zivraj; Christine E Holt
Journal:  Cell       Date:  2012-02-17       Impact factor: 41.582

10.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

View more
  123 in total

1.  Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Authors:  Emmanuelle C Genin; Sylvie Bannwarth; Françoise Lespinasse; Bernardo Ortega-Vila; Konstantina Fragaki; Kie Itoh; Elodie Villa; Sandra Lacas-Gervais; Manu Jokela; Mari Auranen; Emil Ylikallio; Alessandra Mauri-Crouzet; Henna Tyynismaa; Anna Vihola; Gaelle Augé; Charlotte Cochaud; Hiromi Sesaki; Jean-Ehrland Ricci; Bjarne Udd; Cristofol Vives-Bauza; Véronique Paquis-Flucklinger
Journal:  Neurobiol Dis       Date:  2018-08-06       Impact factor: 5.996

2.  CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.

Authors:  Tian Liu; Jung-A A Woo; Mohammed Zaheen Bukhari; Patrick LePochat; Ann Chacko; Maj-Linda B Selenica; Yan Yan; Peter Kotsiviras; Sara Cazzaro Buosi; Xingyu Zhao; David E Kang
Journal:  FASEB J       Date:  2020-05-05       Impact factor: 5.191

Review 3.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

4.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

5.  Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Ju Gao; Luwen Wang; Jingjing Liang; Xinglong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-25

6.  Characterization and Discovery of a Selective Small-Molecule Modulator of Mitochondrial Complex I Targeting a Unique Binding Site.

Authors:  Jakob C Green; Yuqi Jiang; Liu He; Yiming Xu; Dong Sun; Timothy Keoprasert; Christopher Nelson; Unsong Oh; Edward J Lesnefsky; Glen E Kellogg; Qun Chen; Shijun Zhang
Journal:  J Med Chem       Date:  2020-10-02       Impact factor: 7.446

7.  Correcting mitochondrial fusion by manipulating mitofusin conformations.

Authors:  Antonietta Franco; Richard N Kitsis; Julie A Fleischer; Evripidis Gavathiotis; Opher S Kornfeld; Guohua Gong; Nikolaos Biris; Ann Benz; Nir Qvit; Sara K Donnelly; Yun Chen; Steven Mennerick; Louis Hodgson; Daria Mochly-Rosen; Gerald W Dorn
Journal:  Nature       Date:  2016-10-24       Impact factor: 49.962

8.  Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.

Authors:  Jordi Magrané; Czrina Cortez; Wen-Biao Gan; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2013-10-23       Impact factor: 6.150

Review 9.  Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.

Authors:  Diane Moujalled; Anthony R White
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

Review 10.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.